Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 90
Gene Symbol: ACVR1
ACVR1
0.310 GeneticVariation disease LHGDN Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP). 18019378 2007
Entrez Id: 90
Gene Symbol: ACVR1
ACVR1
0.310 Biomarker disease CTD_human
Entrez Id: 9098
Gene Symbol: USP6
USP6
0.030 GeneticVariation disease BEFREE In the following step, using next-generation sequencing, we confirmed the COL1A1-USP6 rearrangement in 5/7 cases of MO and found the same abnormality in 4/5 of FOPD. 30946936 2019
Entrez Id: 9098
Gene Symbol: USP6
USP6
0.030 GeneticVariation disease BEFREE All assessable cases except one (8/9) showed rearrangement of USP6 providing evidence that myositis ossificans is genetically related to nodular fasciitis and aneurysmal bone cyst. 29661729 2018
Entrez Id: 9098
Gene Symbol: USP6
USP6
0.030 GeneticVariation disease LHGDN These findings indicate that a subset of cases with apparent classic histologic and imaging features of MO are rather better classified as being soft-tissue ABC with clonal USP6 rearrangements. 18265974 2008
Entrez Id: 9098
Gene Symbol: USP6
USP6
0.030 GeneticVariation disease BEFREE These findings indicate that a subset of cases with apparent classic histologic and imaging features of MO are rather better classified as being soft-tissue ABC with clonal USP6 rearrangements. 18265974 2008
Entrez Id: 1277
Gene Symbol: COL1A1
COL1A1
0.010 Biomarker disease BEFREE COL1A1 was described as the fusion partner of USP6 in a subset of MO cases, but the fusion partners of USP6-rearranged FOPD have not been uncovered so far. 30946936 2019
Entrez Id: 1800
Gene Symbol: DPEP1
DPEP1
0.010 Biomarker disease BEFREE Higher uptake of [<sup>99m</sup>Tc]MDP in muscle of mdx mice agrees with histological reports of muscle calcification in mdx mice, and suggests the potential translational use of [<sup>99m</sup>Tc]MDP imaging for tracking DMD progression and therapeutic response. 31286350 2019
Entrez Id: 8792
Gene Symbol: TNFRSF11A
TNFRSF11A
0.010 AlteredExpression disease BEFREE Moreover, the expression levels of RANK mRNA were highest in GCTTS, followed by myositis ossificans and PVNS, whereas the expression levels of OPG mRNA were greatly varied among these histological types. 31189751 2019
Entrez Id: 8431
Gene Symbol: NR0B2
NR0B2
0.010 Biomarker disease BEFREE Furthermore, blocking SHP-1 activation in WT macrophages blocked virus-induced myofiber degeneration, and pharmacologic ablation of macrophages inhibited muscle calcification in TMEV-infected WT animals. 25681345 2015
Entrez Id: 5777
Gene Symbol: PTPN6
PTPN6
0.010 Biomarker disease BEFREE Furthermore, blocking SHP-1 activation in WT macrophages blocked virus-induced myofiber degeneration, and pharmacologic ablation of macrophages inhibited muscle calcification in TMEV-infected WT animals. 25681345 2015
Entrez Id: 11173
Gene Symbol: ADAMTS7
ADAMTS7
0.010 AlteredExpression disease BEFREE Upregulation of a disintegrin and metalloproteinase with thrombospondin motifs-7 by miR-29 repression mediates vascular smooth muscle calcification. 22995515 2012
Entrez Id: 6383
Gene Symbol: SDC2
SDC2
0.010 Biomarker disease LHGDN HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells. 17516498 2007
Entrez Id: 9241
Gene Symbol: NOG
NOG
0.010 GeneticVariation disease LHGDN Mutations of the noggin and of the activin A type I receptor genes in fibrodysplasia ossificans progressiva (FOP). 18019378 2007
Entrez Id: 632
Gene Symbol: BGLAP
BGLAP
0.010 AlteredExpression disease BEFREE Despite normal or elevated levels of core-binding factor alpha-1 expression in most specimens, osteocalcin expression was low or undetectable in most cases of osteosarcoma (25 of 34) and myositis ossificans (4 of 5). 10569470 1999
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 AlteredExpression disease BEFREE In this study we analysed by immunohistochemistry the expression of p53 protein in 14 malignant fibrous histocytomas (MFHs), 22 other types of sarcoma (eight leiomyosarcomas, four rhabdomyosarcomas, four liposarcomas, two fibrosarcomas, two chondrosarcomas, one malignant schwannoma, and one dermatofibrosarcoma protuberans), and 25 non-malignant mesenchymal lesions (eight dermatofibromas, four cases of nodular fasciitis, three leiomyomas, three fibromatoses, two epithelioid.leiomyomas, two neurofibromas, one schwannoma, one myositis ossificans, and one giant cell tumour of tendon sheath). 1333524 1992